Articles by Eric Townsend

Page 3 of 483

Elon Law names students to Moot Court Board

September 2, 2020

Twenty-seven students in the Class of 2021 will help lead moot court programs over the next year by participating in upcoming national contests and coordinating Elon Law's own Billings, Exum & Frye National Moot Court Competition.

Elon Law alumni provide counsel on N.C.’s pandemic relief

August 27, 2020

As attorneys for the North Carolina General Assembly, Luke Gillenwater L’11 and Jeremy Ray L’11 assisted state lawmakers this spring with bipartisan legislation aimed at countering the economic and public health damage caused by COVID-19.

Greensboro attorney & community leader: ‘Be open to opportunities’

August 6, 2020

In Convocation remarks to Elon Law’s Class of 2022, Kimberly Bullock Gatling, one of North Carolina’s most prominent intellectual property attorneys, encouraged students to “try a little bit of everything” as they begin their legal education in an era of unprecedented global challenges.

NPR interviews Elon Law scholar for report on Portland protests

August 1, 2020

Elon Law Associate Dean Enrique Armijo spoke with National Public Radio for a story on the conditions of pre-trial release for some demonstrators charged by federal authorities in Portland, Oregon, and how those conditions may violate the First Amendment.

Elon Law program director to co-lead national webinar series on strangulation

July 20, 2020

Margaret Dudley of the law school’s Emergency Legal Services Program will team teach a webinar developed by the American Bar Association and Alliance for HOPE International’s Training Institute on Strangulation Prevention to help civil attorneys recognize what has been called "one of the most lethal forms of domestic violence" and better advocate for victims in court.

Elon Law scholar weighs trade secrecy vs. COVID medicine for STAT

July 10, 2020

A guest column by Professor David S. Levine in STAT, one of the nation's most influential news sources related to health and medicine, warns that existing trade secrecy laws could slow the discovery and production of therapeutics in today's global pandemic.